PT83186B - Processo para a preparacao de uma modificacao estavel de1-isopropil-3-{(4-m-toluidino-3-piridil)-sulfonil}-ureia (torasemida) e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de uma modificacao estavel de1-isopropil-3-{(4-m-toluidino-3-piridil)-sulfonil}-ureia (torasemida) e de composicoes farmaceuticas que os contem

Info

Publication number
PT83186B
PT83186B PT83186A PT8318686A PT83186B PT 83186 B PT83186 B PT 83186B PT 83186 A PT83186 A PT 83186A PT 8318686 A PT8318686 A PT 8318686A PT 83186 B PT83186 B PT 83186B
Authority
PT
Portugal
Prior art keywords
torasemida
sulphonyl
toluidine
pyridyl
urea
Prior art date
Application number
PT83186A
Other languages
English (en)
Portuguese (pt)
Other versions
PT83186A (de
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of PT83186A publication Critical patent/PT83186A/pt
Publication of PT83186B publication Critical patent/PT83186B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Enzymes And Modification Thereof (AREA)
PT83186A 1985-08-17 1986-08-12 Processo para a preparacao de uma modificacao estavel de1-isopropil-3-{(4-m-toluidino-3-piridil)-sulfonil}-ureia (torasemida) e de composicoes farmaceuticas que os contem PT83186B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853529529 DE3529529A1 (de) 1985-08-17 1985-08-17 Verfahren zur herstellung einer stabilen modifikation von torasemid

Publications (2)

Publication Number Publication Date
PT83186A PT83186A (de) 1986-09-01
PT83186B true PT83186B (pt) 1988-07-01

Family

ID=6278766

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83186A PT83186B (pt) 1985-08-17 1986-08-12 Processo para a preparacao de uma modificacao estavel de1-isopropil-3-{(4-m-toluidino-3-piridil)-sulfonil}-ureia (torasemida) e de composicoes farmaceuticas que os contem

Country Status (25)

Country Link
US (4) US4743693A (en:Method)
EP (1) EP0212537B1 (en:Method)
JP (2) JPS6245576A (en:Method)
KR (1) KR930009818B1 (en:Method)
AU (1) AU573454B2 (en:Method)
CA (1) CA1307277C (en:Method)
CS (2) CS259891B2 (en:Method)
DD (1) DD259858A5 (en:Method)
DE (2) DE3529529A1 (en:Method)
DK (1) DK162518C (en:Method)
ES (1) ES2001522A6 (en:Method)
FI (1) FI82189C (en:Method)
GR (1) GR862139B (en:Method)
HK (1) HK59994A (en:Method)
HU (1) HU195778B (en:Method)
IE (1) IE59237B1 (en:Method)
IL (1) IL79672A (en:Method)
LT (1) LT3596B (en:Method)
NO (1) NO170079C (en:Method)
NZ (1) NZ217172A (en:Method)
PL (1) PL146086B1 (en:Method)
PT (1) PT83186B (en:Method)
SU (1) SU1480766A3 (en:Method)
UA (1) UA7080A1 (en:Method)
ZA (1) ZA866151B (en:Method)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623620A1 (de) * 1986-07-12 1988-01-21 Boehringer Mannheim Gmbh Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
US5166162A (en) * 1990-03-02 1992-11-24 Adir Et Compagnie Pyridylsulfonylurea and pyridylsulfonylthiourea compounds
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
TW257757B (en:Method) * 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
HRP980532B1 (en) 1998-10-02 2005-06-30 Pliva Novel crystalline torasemide modification
US6166045A (en) 1998-06-02 2000-12-26 Roche Diagnostics Gmbh Torasemide of modification III
US5914336A (en) 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
HRP20020120A2 (en) 1999-08-11 2003-10-31 Teva Pharma Torsemide polymorphs
EP1292303B1 (en) * 2000-02-17 2004-05-12 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation comprising torsemide modification ii
NZ521852A (en) 2000-03-20 2004-10-29 Teva Pharma Novel processes for preparing torsemide intermediate
HRP20000162B1 (en) * 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
HRP20000765A2 (en) * 2000-11-10 2002-06-30 Pliva D D Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
IN192178B (en:Method) * 2001-08-03 2004-03-06 Ranbaxy Lab
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
ITMI20020639A1 (it) * 2002-03-27 2003-09-29 Cosma S P A Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea
HRP20020603B1 (en) * 2002-07-19 2008-11-30 Pliva D.D. New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
DE60312953T2 (de) * 2002-11-18 2007-12-13 Teva Pharmaceutical Industries Ltd. Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol
CA2515130A1 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Method of stabilizing lansoprazole
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
AT500576B1 (de) * 2004-07-28 2006-11-15 Sanochemia Pharmazeutika Ag Verfahren zur reindarstellung von kristallformen von torsemid
US10178893B1 (en) * 2013-06-14 2019-01-15 Scott Bradley Baker Shoe
FR3018688A1 (fr) * 2014-03-19 2015-09-25 Virbac Utilisation de torasemide a faible dose dans une composition veterinaire
US12048677B2 (en) 2014-12-12 2024-07-30 Ceva Sante Animale Compositions and uses thereof for the treatment of heart failure in domestic animals
EP3031471A1 (en) * 2014-12-12 2016-06-15 Ceva Sante Animale Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals
SI3173075T1 (sl) * 2015-11-27 2019-02-28 Accupharma Spolka Z Ograniczona Odpowiedzialnoscia Farmacevtski kombinacijski pripravek inhibitorja ACE in diuretika zanke
CN115417810B (zh) * 2022-09-22 2023-10-10 南京正科医药股份有限公司 一种托拉塞米晶型ⅰ的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US30633A (en) * 1860-11-13 Improvement in fire-escapes
GB1477664A (en) * 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
LU85193A1 (fr) * 1984-01-31 1985-09-12 Christiaens Sa A Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation

Also Published As

Publication number Publication date
AU6105586A (en) 1987-02-19
CS259891B2 (en) 1988-11-15
KR870002076A (ko) 1987-03-30
UA7080A1 (uk) 1995-06-30
DK162518C (da) 1992-03-30
NO170079C (no) 1992-09-09
DK385586A (da) 1987-02-18
ZA866151B (en) 1987-04-29
ES2001522A6 (es) 1988-06-01
HUT42069A (en) 1987-06-29
JPS6245576A (ja) 1987-02-27
NO170079B (no) 1992-06-01
JPH0643400B2 (ja) 1994-06-08
IE862179L (en) 1987-02-17
FI863305A0 (fi) 1986-08-15
FI82189B (fi) 1990-10-31
USRE34580E (en) 1994-04-05
US4822807A (en) 1989-04-18
HU195778B (en) 1988-07-28
US4743693A (en) 1988-05-10
IE59237B1 (en) 1994-01-26
DE3529529C2 (en:Method) 1987-05-27
NZ217172A (en) 1989-02-24
DE3667970D1 (de) 1990-02-08
FI863305L (fi) 1987-02-18
DK385586D0 (da) 1986-08-13
USRE34672E (en) 1994-07-26
JPH0415205B2 (en:Method) 1992-03-17
LT3596B (en) 1995-12-27
JPH02191255A (ja) 1990-07-27
KR930009818B1 (ko) 1993-10-11
IL79672A (en) 1990-01-18
LTIP898A (en) 1995-03-27
PL261052A1 (en) 1987-11-02
FI82189C (fi) 1991-02-11
PT83186A (de) 1986-09-01
DE3529529A1 (de) 1987-02-19
DK162518B (da) 1991-11-11
CA1307277C (en) 1992-09-08
CS594586A2 (en) 1988-03-15
EP0212537A1 (de) 1987-03-04
SU1480766A3 (ru) 1989-05-15
CS419991A3 (en) 1992-06-17
DD259858A5 (de) 1988-09-07
EP0212537B1 (de) 1990-01-03
NO863305L (no) 1987-02-18
GR862139B (en) 1986-12-30
IL79672A0 (en) 1986-11-30
PL146086B1 (en) 1988-12-31
NO863305D0 (no) 1986-08-15
AU573454B2 (en) 1988-06-09
HK59994A (en) 1994-07-08

Similar Documents

Publication Publication Date Title
PT83186B (pt) Processo para a preparacao de uma modificacao estavel de1-isopropil-3-{(4-m-toluidino-3-piridil)-sulfonil}-ureia (torasemida) e de composicoes farmaceuticas que os contem
PT83610B (pt) Processo para a preparacao de analogos heterociclicos de mevalolactona e seus derivados e de composicoes farmaceuticas que os contem
PT82226B (pt) Processo para a preparacao de 3-ariluracilos e de composicoes herbicidas que os contem
PT80892B (pt) Processo para a preparacao de derivados da quoinona e de composicoes farmaceuticas que os contem
PT82591B (pt) Processo para a preparacao de derivados do acido ascorbico e de composicoes farmaceuticas que os contem
PT84319B (pt) Processo para a preparacao de derivados substituidos de tienoimidazol e de composicoes farmaceuticas que os contem
PT82985B (pt) Processo para a preparacao de derivados de distamicina e de composicoes farmaceuticas que os contem
PT84704B (pt) Processo para a preparacao de derivados do acido tiolactam-n-acetico e de composicoes farmaceuticas que os contem
PT81041B (pt) Processo para a preparacao de derivados de etilenodiamina-monoamida e de composicoes farmaceuticas que os contem
PT80363B (pt) Processo para a preparacao de derivados de fenol e de composicoes farmaceuticas que os contem
PT83558B (pt) Processo para a preparacao de derivados da carboxamida e de composicoes farmaceuticas que os contem
PT82307B (pt) Processo para a preparacao de derivados da 4'-demetil-4-epipodofilotoxina e de composicoes farmaceuticas que os contem
PT83260B (pt) Processo para a preparacao de compostos derivados da espergualina e de composicoes farmaceuticas que os contem
PT83495B (pt) Processo para a preparacao de difenilpiperidinas n-substituidas e de composicoes farmaceuticas que as contem
PT84462B (pt) Rocesso para a preparacao de novos tiazois e oxazois substituidos e de composicoes farmaceuticas que os contem
PT84187B (pt) Processo para a preparacao de novos derivados da isoquinolina e de composicoes farmaceuticas que os contem
PT83559B (pt) Processo para a preparacao de novos derivados de indol e indazol-ceto-sulfona e de composicoes farmaceuticas que os contem
PT83604B (pt) Processo para a preparacao de derivados da flavona e de composicoes farmaceuticas que os contem
PT83565B (pt) Processo para a preparacao de derivados do acido aril-heterociclil-alcoxi-acetico e de composicoes farmaceuticas que os contem
PT89145A (pt) Processo para a preparacao de derivados da manumicina e de composicoes farmaceuticas que os contem
PT88351A (pt) Processo para a preparacao de derivados de isoxazol-beta-carbolina e de composicoes farmaceuticas que os contem
PT82901B (pt) Processo para a preparacao de derivados do acido antranilico dotados de accao terapeutica e de composicoes farmaceuticas que os contem
PT82440B (pt) Processo para a preparacao de eteres ciclopentilicos e de composicoes farmaceuticas que os contem
PT82399B (pt) Processo para a preparacao de derivados de fenetanolamina e de composicoes farmaceuticas que os contem
PT82167B (pt) Processo para a preparacao de sulfureto heterociclicos e de composicoes farmceuticas que os contem